Wolverine Trading, LLC Clovis Oncology, Inc. Put Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Put Options

18 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 15, 2022	BUY	$0.63 - $2.96 $22,302 - $104,784	35,400 Added 252.86%	49,400 $84,000
Q1 2022 May 16, 2022	BUY	$1.43 - $3.14 $1,430 - $3,140	1,000 Added 7.69%	14,000 $23,000
Q4 2021 Feb 14, 2022	SELL	$2.7 - $4.76 $73,710 - $129,948	-27,300 Reduced 67.74%	13,000 $37,000
Q3 2021 Nov 12, 2021	SELL	$4.06 - $5.8 $112,867 - $161,240	-27,800 Reduced 40.82%	40,300 $182,000
Q2 2021 Aug 06, 2021	SELL	$5.02 - $7.05 $31,123 - $43,710	-6,200 Reduced 8.34%	68,100 $398,000
Q1 2021 May 14, 2021	BUY	$4.81 - $10.34 $35,113 - $75,482	7,300 Added 10.9%	74,300 $504,000
Q4 2020 Feb 12, 2021	BUY	$4.13 - $6.41 $97,881 - $151,917	23,700 Added 54.73%	67,000 $330,000
Q3 2020 Nov 13, 2020	SELL	$4.82 - $7.72 $77,120 - $123,520	-16,000 Reduced 26.98%	43,300 $257,000
Q2 2020 Aug 13, 2020	BUY	$5.69 - $9.69 $337,417 - $574,617	59,300 New	59,300 $417,000
Q4 2019 Feb 12, 2020	SELL	$3.0 - $16.43 $95,700 - $524,117	-31,900 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$3.93 - $15.35 $29,082 - $113,590	7,400 Added 30.2%	31,900 $128,000
Q2 2019 Aug 20, 2019	SELL	$12.81 - $25.67 $185,745 - $372,215	-14,500 Reduced 37.18%	24,500 $364,000
Q1 2019 May 15, 2019	SELL	$17.66 - $30.28 $143,046 - $245,268	-8,100 Reduced 17.2%	39,000 $968,000
Q4 2018 Feb 14, 2019	BUY	$11.63 - $32.67 $211,666 - $594,594	18,200 Added 62.98%	47,100 $846,000
Q3 2018 Nov 14, 2018	SELL	$29.37 - $49.48 $308,385 - $519,539	-10,500 Reduced 26.65%	28,900 $849,000
Q1 2018 May 15, 2018	SELL	$50.12 - $67.72 $2.92 Million - $3.95 Million	-58,300 Reduced 59.67%	39,400 $2.08 Million
Q4 2017 Feb 14, 2018	SELL	$57.69 - $84.58 $998,037 - $1.46 Million	-17,300 Reduced 15.04%	97,700 $6.64 Million
Q3 2017 Nov 15, 2017	BUY	$67.17 - $84.81 $7.72 Million - $9.75 Million	115,000	115,000 $9.48 Million

Others Institutions Holding CLVS

# of Institutions

Shares Held

166

Call Options Held

Put Options Held

Exane Derivatives

166
Shares

$14
0.0% of portfolio

View Full List

About Clovis Oncology, Inc.

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

More about CLVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account